Clinical Trial Update: A Multiple Ascending Dose Study of R1530 in Patients With Advanced Solid Tumors. [Phase 1]

View source ↗

Summary

A Phase 1 multiple ascending dose study of the experimental drug R1530 in patients with advanced solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• R1530

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Neoplasms | Phase 1 | Status: COMPLETED